Health ❯ Healthcare ❯ Clinical Trials

Patient Outcomes

Survival Rates Quality of Life Remission Rates Mortality Rates Gender Differences Risk Stratification Treatment Efficacy Cancer Treatment Efficacy Treatment Response Precision Medicine

Study Details VeloCD Blood Method to Predict Illness Trajectory

The peer-reviewed proof-of-concept points to faster triage pending larger trials.

AI Blood Test Maps Tumor Neighborhoods and Predicts Immunotherapy Response

New CAR-T Designs Deliver Low-Dose Remissions and Expose a Senescence Risk

FDA Approves First Gene Therapy for Inherited Hearing Loss

AI Pathomics Tool Beats PD-L1 at Predicting Lung Cancer Immunotherapy Benefit

Studies Link GLP-1 Drugs to Lower Addiction and Overdose Risks

NIH-Supported Study Unveils Four-Marker Blood Test for Earlier Detection of Pancreatic Cancer

First Pivotal Trial Finds Cooled-Laser Prostate Therapy Effective at 3 Months With Low Morbidity

First NHS Patient Completes Next‑Generation CAR‑T Therapy for Aggressive Leukaemia

Immune Atlas Sharpens Myeloma Risk Prediction as Dual-Target CAR T Counters BCMA Loss

Vegetable-Based Supplement Plus Probiotic Slows PSA Rise in Low-Risk Prostate Cancer

Lilly’s Daily Obesity Pill Sustains Weight Loss After Switch From Wegovy or Zepbound

Lilly’s Triple-Agonist Retatrutide Shows Major Phase 3 Weight Loss as Grey-Market Use Prompts Warning

EMA Panel Backs Conditional EU Approval for Anktiva in BCG-Unresponsive Bladder Cancer

Base-Edited Donor CAR-T Yields 82% Transplant-Eligible Remission in Early T-Cell Leukemia Trial

Sacituzumab Govitecan Gains First-Line Ground in TNBC, Falls Short in Early HR+/HER2− Use

UK Trial’s Base-Edited Off-the-Shelf CAR T Cells Deliver Durable Remissions in T-Cell Leukemia

Immunotherapy Before 3 p.m. Linked to Longer Survival in Small Cell Lung Cancer

Base-Edited Donor T Cells Induce Remissions in T-Cell Leukemia, NEJM Study Reports

Wave Life Sciences Soars on Obesity Trial Signal as It Begins $250 Million Stock Offering